111 – 120 of 210
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Breathlessness Isn't Cool, But Its Treatment Can Be
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Editorial : Respiratory problems
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Quality of Life Changes With Duration of Chronic Breathlessness : A Random Sample of Community-Dwelling People
(
- Contribution to journal › Article
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
(
- Contribution to journal › Article
-
Mark
Observational studies and "the eye of the beholder"
(
- Contribution to journal › Letter
-
Mark
Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial
(
- Contribution to journal › Article
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
(
- Contribution to journal › Article
-
Mark
Course of DISease in patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls
(
- Contribution to journal › Article